Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
39
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Puri Michal Nath | Chief Human Resources Officer | 19 | $0 | $102.7K | 2026-06-30 |
| Ben Arye Barak | General Counsel | 17 | $0 | $0 | 2026-06-30 |
| Leonard Frank X | President, CNS Cancers US | 108 | $0 | $14.14M | 2026-06-30 |
| Danziger Asaf | Director | 197 | $659.5K | $201.82M | 2026-06-30 |
| Stafford Kristin | Director | 10 | $0 | $63.7K | 2026-06-03 |
| Ocean Allyson J | Director | 8 | $0 | $63.7K | 2026-06-03 |
| Madden Martin J. | Director | 21 | $0 | $22.4K | 2026-06-03 |
| Scannell Timothy J | Director | 13 | $0 | $86.8K | 2026-06-03 |
| VERNON W ANTHONY | Director | 29 | $0 | $9.19M | 2026-06-03 |
| Hung David | Director | 18 | $0 | $63.7K | 2026-06-03 |
| LEUNG GABRIEL | Director | 150 | $0 | $24.16M | 2026-06-03 |
| HILLEMAN JERYL L | Director | 20 | $0 | $508.0K | 2026-06-03 |
| Paravasthu Mukund | Chief Operating Officer | 25 | $0 | $849.6K | 2026-03-05 |
| Brackmann Christoph | Chief Financial Officer | 9 | $231.8K | $85.3K | 2026-03-04 |
| Leupin Nicolas | Former Chief Medical Officer | 10 | $0 | $68.4K | 2026-03-04 |
| Cordova Ashley | Former Chief Executive Officer | 88 | $996.5K | $5.71M | 2026-03-04 |
| Weinberg Uri | Chief Science Officer | 56 | $0 | $6.09M | 2026-03-04 |
| DOYLE WILLIAM F | Executive Chairman | 115 | $0 | $73.23M | 2026-03-03 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 336 | $0 | $64.69M | 2024-06-28 |
| Giladi Moshe | Chief Science Officer | 2 | $0 | $0 | 2024-02-27 |
| Shah Pritesh | Chief Growth Officer | 171 | $357.0K | $26.86M | 2023-11-07 |
| Burke William Patrick | Chief Human Resources Officer | 25 | $0 | $651.3K | 2023-06-30 |
| Benaim Ely | Chief Medical Officer | 60 | $0 | $5.72M | 2023-01-06 |
| Longsworth Todd Christopher | General Counsel | 109 | $0 | $31.10M | 2022-03-08 |
| McCoy Sherilyn S | Director | 7 | $0 | $0 | 2021-06-09 |
| Ambrogi Michael J. | Chief Operating Officer | 173 | $0 | $44.38M | 2020-07-22 |
| Wyss Hansjoerg | 10% Owner | 5 | $0 | $0 | 2019-12-20 |
| PHILLIPS CHARLES G III | Director | 35 | $0 | $9.02M | 2019-12-02 |
| Burkoth William T. | Director | 6 | $0 | $0 | 2019-05-21 |
| Kirson Eilon D. | Chief Science Officer | 58 | $0 | $24.29M | 2019-02-27 |
| Palti Yoram | Chief Technology Officer | 77 | $0 | $15.75M | 2018-08-28 |
| LAVIGNE LOUIS J JR | Director | 6 | $0 | $0 | 2018-05-31 |
| FUTRELL STEVE | 10% Owner | 4 | $0 | $18.61M | 2017-06-26 |
| Perlhagen Gert L. | Director, 10% Owner | 22 | $866.3K | $1.25M | 2017-05-10 |
| Melnyk Peter M. | Chief Commercial Officer | 2 | $0 | $0 | 2017-01-06 |
| Volati Ltd | 10% Owner | 3 | $0 | $0 | 2016-08-05 |
| WFD Ventures Fund II, L.P. | 10% Owner | 18 | $0 | $0 | 2016-05-06 |
| Langloss Timothy J. | Director | 2 | $0 | $0 | 2016-05-05 |
| MYLOD ROBERT J JR | Director | 4 | $315.6K | $0 | 2016-05-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Danziger Asaf | Director | A Award | 2026-06-30 | 2026-07-01 | 268 | $11.15 | $3.0K | 416,742 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2026-06-30 | 2026-07-01 | 1,299 | $11.15 | $14.5K | 243,752 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | A Award | 2026-06-30 | 2026-07-01 | 1,905 | $11.15 | $21.2K | 461,425 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2026-06-30 | 2026-07-01 | 1,905 | $11.15 | $21.2K | 203,227 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | S Sale | 2026-06-04 | 2026-06-05 | 34,273 | $17.93 | $614.5K | 459,520 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| Madden Martin J. | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| Hung David | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| Scannell Timothy J | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| Ocean Allyson J | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| Stafford Kristin | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| LEUNG GABRIEL | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 209,267 | SEC↗ |
| Madden Martin J. | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 30,284 | SEC↗ |
| Hung David | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 32,075 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 25,471 | SEC↗ |
| Scannell Timothy J | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 25,898 | SEC↗ |
| Ocean Allyson J | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 22,934 | SEC↗ |
| Stafford Kristin | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 22,934 | SEC↗ |
| LEUNG GABRIEL | Director | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 101,109 | SEC↗ |
| Hung David | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 20,465 | SEC↗ |
| VERNON W ANTHONY | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 197,657 | SEC↗ |
| HILLEMAN JERYL L | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 13,861 | SEC↗ |
| Scannell Timothy J | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 14,288 | SEC↗ |
| Ocean Allyson J | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 11,324 | SEC↗ |
| Stafford Kristin | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 11,324 | SEC↗ |
| LEUNG GABRIEL | Director | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 89,499 | SEC↗ |
| VERNON W ANTHONY | Director | M Exercise deriv | 2026-04-28 | 2026-04-28 | 21,500 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | M Exercise | 2026-04-28 | 2026-04-28 | 21,500 | $11.39 | $244.9K | 200,602 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2026-03-05 | 2026-03-05 | 43,246 | $13.77 | $595.5K | 72,832 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2026-03-04 | 2026-03-05 | 1,100 | $13.31 | $14.6K | 201,322 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2026-03-04 | 2026-03-05 | 5,377 | $13.31 | $71.6K | 116,078 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | S Sale | 2026-03-04 | 2026-03-05 | 5,607 | $13.31 | $74.6K | 493,793 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-05 | 6,412 | $13.31 | $85.3K | 182,842 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | S Sale | 2026-03-04 | 2026-03-05 | 6,412 | $13.31 | $85.3K | 267,190 | SEC↗ |
| Cordova Ashley | Former Chief Executive Offic | F Tax w/h | 2026-03-04 | 2026-03-05 | 17,638 | $13.30 | $234.6K | 422,570 | SEC↗ |
| Leupin Nicolas | Former Chief Medical Officer | S Sale | 2026-03-04 | 2026-03-05 | 1,100 | $13.31 | $14.6K | 102,979 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | A Award deriv | 2026-03-03 | 2026-03-05 | 258,445 | — | $0 | 258,445 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | A Award deriv | 2026-03-03 | 2026-03-05 | 30,072 | — | $0 | 288,517 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award deriv | 2026-03-03 | 2026-03-05 | 58,672 | — | $0 | 58,672 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award deriv | 2026-03-03 | 2026-03-05 | 58,488 | — | $0 | 66,006 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award deriv | 2026-03-03 | 2026-03-05 | 7,518 | — | $0 | 7,518 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | A Award deriv | 2026-03-03 | 2026-03-05 | 216,388 | — | $0 | 216,388 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | A Award deriv | 2026-03-03 | 2026-03-05 | 80,674 | — | $0 | 80,674 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | A Award deriv | 2026-03-03 | 2026-03-05 | 73,340 | — | $0 | 73,340 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award deriv | 2026-03-03 | 2026-03-05 | 73,340 | — | $0 | 73,340 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | A Award | 2026-03-03 | 2026-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | S Sale | 2026-03-03 | 2026-03-05 | 50,557 | $12.79 | $646.6K | 349,727 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | S Sale | 2026-03-03 | 2026-03-05 | 21,330 | $13.43 | $286.5K | 328,397 | SEC↗ |
| DOYLE WILLIAM F | Executive Chairman | A Award | 2026-03-03 | 2026-03-05 | 200,284 | — | $0 | 400,284 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2026-03-03 | 2026-03-05 | 40,100 | — | $0 | 202,422 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award | 2026-03-03 | 2026-03-05 | 45,112 | — | $0 | 121,455 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | A Award | 2026-03-03 | 2026-03-05 | 150,000 | — | $0 | 499,400 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | A Award | 2026-03-03 | 2026-03-05 | 55,137 | — | $0 | 189,254 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | A Award | 2026-03-03 | 2026-03-05 | 50,125 | — | $0 | 273,602 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2026-03-03 | 2026-03-05 | 50,125 | — | $0 | 242,453 | SEC↗ |
| Cordova Ashley | Former Chief Executive Offic | F Tax w/h | 2026-03-02 | 2026-03-03 | 7,228 | $13.67 | $98.8K | 440,208 | SEC↗ |
| Cordova Ashley | Former Chief Executive Offic | F Tax w/h | 2026-03-02 | 2026-03-03 | 2,410 | $13.67 | $32.9K | 447,436 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-03 | 7,232 | $13.49 | $97.6K | 349,400 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2026-03-02 | 2026-03-03 | 408 | $13.49 | $5.5K | 76,343 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | S Sale | 2026-03-02 | 2026-03-03 | 3,272 | $13.33 | $43.6K | 223,477 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2026-02-28 | 2026-03-03 | 17,755 | — | $0 | 192,328 | SEC↗ |
| Cordova Ashley | Former Chief Executive Offic | A Award | 2026-02-28 | 2026-03-03 | 23,818 | — | $0 | 449,846 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | A Award | 2026-02-28 | 2026-03-03 | 18,621 | — | $0 | 356,632 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | A Award | 2026-02-28 | 2026-03-03 | 12,992 | — | $0 | 226,749 | SEC↗ |
| Cordova Ashley | Former Chief Executive Offic | F Tax w/h | 2026-02-27 | 2026-03-03 | 11,541 | $13.75 | $158.7K | 426,028 | SEC↗ |
| Leonard Frank X | Chief Executive Officer | S Sale | 2026-02-27 | 2026-03-03 | 9,734 | $13.66 | $133.0K | 338,011 | SEC↗ |
| Leupin Nicolas | Former Chief Medical Officer | S Sale | 2026-02-27 | 2026-03-03 | 1,029 | $13.66 | $14.1K | 104,079 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2026-02-27 | 2026-03-03 | 1,555 | $13.66 | $21.2K | 76,751 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2026-02-27 | 2026-03-03 | 1,441 | $13.66 | $19.7K | 162,322 | SEC↗ |
| Weinberg Uri | Chf Medical and Innovation O | S Sale | 2026-02-27 | 2026-03-03 | 7,461 | $13.84 | $103.3K | 213,757 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | F Tax w/h | 2026-01-11 | 2026-01-12 | 2,133 | $14.35 | $30.6K | 78,306 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | F Tax w/h | 2025-11-04 | 2025-11-04 | 2,949 | $12.23 | $36.1K | 80,439 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | F Tax w/h | 2025-11-04 | 2025-11-04 | 7,033 | $12.23 | $86.0K | 134,117 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | F Tax w/h | 2025-11-01 | 2025-11-04 | 966 | $12.81 | $12.4K | 347,745 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | F Tax w/h | 2025-11-01 | 2025-11-04 | 168 | $12.81 | $2.2K | 83,388 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | F Tax w/h | 2025-10-31 | 2025-11-04 | 752 | $12.82 | $9.6K | 163,762 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | P Buy | 2025-09-05 | 2025-09-08 | 81,550 | $12.22 | $996.5K | 437,569 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | P Buy | 2025-07-29 | 2025-07-30 | 5,000 | $11.60 | $58.0K | 136,150 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | P Buy | 2025-07-29 | 2025-07-30 | 5,000 | $11.50 | $57.5K | 141,150 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | P Buy | 2025-07-29 | 2025-07-30 | 10,000 | $11.63 | $116.3K | 131,150 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2025-06-30 | 2025-07-01 | 769 | $15.13 | $11.6K | 174,465 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | A Award | 2025-06-30 | 2025-07-01 | 833 | $15.13 | $12.6K | 356,019 | SEC↗ |
| Danziger Asaf | Director | A Award | 2025-06-30 | 2025-07-01 | 833 | $15.13 | $12.6K | 416,473 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award | 2025-06-30 | 2025-07-01 | 833 | $15.13 | $12.6K | 348,711 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2025-06-30 | 2025-07-01 | 833 | $15.13 | $12.6K | 164,514 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| Hung David | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| Scannell Timothy J | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| Ocean Allyson J | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| Madden Martin J. | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 33,393 | — | $0 | 33,393 | SEC↗ |
| Stafford Kristin | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| LEUNG GABRIEL | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award | 2025-06-04 | 2025-06-06 | 179,426 | — | $0 | 347,878 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 179,102 | SEC↗ |
| Hung David | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 23,410 | SEC↗ |
| Scannell Timothy J | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 17,233 | SEC↗ |
| Ocean Allyson J | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 14,269 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 16,806 | SEC↗ |
| Stafford Kristin | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 14,269 | SEC↗ |
| LEUNG GABRIEL | Director | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 92,444 | SEC↗ |
| Hung David | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.30 | $17.3K | 12,195 | SEC↗ |
| VERNON W ANTHONY | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.35 | $17.3K | 167,887 | SEC↗ |
| Ocean Allyson J | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.29 | $17.3K | 3,054 | SEC↗ |
| HILLEMAN JERYL L | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.26 | $17.2K | 5,591 | SEC↗ |
| Scannell Timothy J | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.32 | $17.3K | 6,018 | SEC↗ |
| Madden Martin J. | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.19 | $17.2K | 18,674 | SEC↗ |
| LEUNG GABRIEL | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.31 | $17.3K | 81,229 | SEC↗ |
| Stafford Kristin | Director | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.28 | $17.3K | 3,054 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-06-02 | 2025-06-04 | 1,879 | $19.01 | $35.7K | 168,452 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-06-02 | 2025-06-04 | 6,600 | $17.99 | $118.7K | 170,331 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-06-02 | 2025-06-04 | 21,717 | $17.22 | $374.0K | 176,931 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-05-03 | 2025-05-05 | 592 | $17.91 | $10.6K | 83,556 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | A Award deriv | 2025-03-04 | 2025-03-06 | 224,123 | $18.19 | $4.08M | 224,123 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | A Award deriv | 2025-03-04 | 2025-03-06 | 81,499 | $18.19 | $1.48M | 81,499 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | A Award | 2025-03-04 | 2025-03-06 | 151,181 | $18.19 | $2.75M | 355,186 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 84,148 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 198,648 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 221,218 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 163,681 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 173,696 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 105,108 | SEC↗ |
| Brackmann Christoph | Chief Financial Officer | A Award | 2025-03-04 | 2025-03-06 | 54,975 | $18.19 | $1000.0K | 121,150 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-04 | 250 | $18.54 | $4.6K | 29,173 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-04 | 2,053 | $18.54 | $38.1K | 204,005 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-03-03 | 2025-03-04 | 2,527 | $18.54 | $46.9K | 143,673 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | S Sale | 2025-03-03 | 2025-03-04 | 268 | $18.92 | $5.1K | 166,243 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-28 | 2025-03-03 | 368 | $18.28 | $6.7K | 29,423 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-28 | 2025-03-03 | 2,341 | $18.28 | $42.8K | 206,058 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-28 | 2025-03-03 | 2,770 | $18.28 | $50.6K | 146,200 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | S Sale | 2025-02-28 | 2025-03-03 | 4,326 | $18.78 | $81.2K | 166,822 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | S Sale | 2025-02-28 | 2025-03-03 | 311 | $18.31 | $5.7K | 166,511 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-28 | 2025-03-03 | 368 | $18.28 | $6.7K | 29,423 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-28 | 2025-03-03 | 2,770 | $18.28 | $50.6K | 146,200 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-28 | 2025-03-03 | 2,341 | $18.28 | $42.8K | 206,058 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | S Sale | 2025-02-28 | 2025-03-03 | 4,326 | $18.78 | $81.2K | 166,822 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | S Sale | 2025-02-28 | 2025-03-03 | 311 | $18.31 | $5.7K | 166,511 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-27 | 2025-03-03 | 1,379 | $19.92 | $27.5K | 30,058 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-27 | 2025-03-03 | 267 | $20.55 | $5.5K | 29,791 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-27 | 2025-03-03 | 9,345 | $19.92 | $186.2K | 210,207 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-27 | 2025-03-03 | 1,808 | $20.55 | $37.2K | 208,399 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-27 | 2025-03-03 | 1,989 | $20.55 | $40.9K | 148,970 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-27 | 2025-03-03 | 10,277 | $19.92 | $204.7K | 150,959 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2025-02-27 | 2025-03-03 | 1,162 | $19.92 | $23.1K | 108,931 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2025-02-27 | 2025-03-03 | 225 | $20.55 | $4.6K | 108,706 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | S Sale | 2025-02-27 | 2025-03-03 | 161 | $20.55 | $3.3K | 50,133 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | S Sale | 2025-02-27 | 2025-03-03 | 830 | $19.92 | $16.5K | 50,294 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-27 | 2025-03-03 | 267 | $20.55 | $5.5K | 29,791 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-02-27 | 2025-03-03 | 1,379 | $19.92 | $27.5K | 30,058 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | S Sale | 2025-02-27 | 2025-03-03 | 830 | $19.92 | $16.5K | 50,294 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | S Sale | 2025-02-27 | 2025-03-03 | 161 | $20.55 | $3.3K | 50,133 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2025-02-27 | 2025-03-03 | 1,162 | $19.92 | $23.1K | 108,931 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2025-02-27 | 2025-03-03 | 225 | $20.55 | $4.6K | 108,706 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-27 | 2025-03-03 | 1,989 | $20.55 | $40.9K | 148,970 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2025-02-27 | 2025-03-03 | 10,277 | $19.92 | $204.7K | 150,959 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-27 | 2025-03-03 | 1,808 | $20.55 | $37.2K | 208,399 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | S Sale | 2025-02-27 | 2025-03-03 | 9,345 | $19.92 | $186.2K | 210,207 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2025-01-11 | 2025-01-15 | 2,160 | $26.81 | $57.9K | 31,437 | SEC↗ |
| Danziger Asaf | Director | A Award | 2025-01-01 | 2025-01-03 | 400,000 | — | $0 | 415,640 | SEC↗ |
| Danziger Asaf | Director | A Award | 2024-12-31 | 2025-01-03 | 412 | $14.75 | $6.1K | 15,640 | SEC↗ |
| Cordova Ashley | Chief Executive Officer | A Award | 2024-12-31 | 2025-01-03 | 373 | $14.75 | $5.5K | 219,552 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2024-12-31 | 2025-01-03 | 669 | $14.75 | $9.9K | 118,721 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award deriv | 2024-11-04 | 2024-11-06 | 45,620 | $16.59 | $756.8K | 45,620 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | A Award | 2024-11-04 | 2024-11-06 | 30,138 | — | $0 | 33,597 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2024-11-02 | 2024-11-06 | 44 | $16.69 | $734 | 3,459 | SEC↗ |
| Paravasthu Mukund | Chief Operating Officer | S Sale | 2024-11-01 | 2024-11-04 | 160 | $15.88 | $2.5K | 3,503 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2024-11-01 | 2024-11-04 | 598 | $15.94 | $9.5K | 161,236 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | S Sale | 2024-10-31 | 2024-11-04 | 810 | $15.79 | $12.8K | 110,093 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2024-08-02 | 2024-08-05 | 688 | $20.14 | $13.9K | 219,179 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2024-06-28 | 2024-08-06 | 1,736 | $12.24 | $21.2K | 110,903 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award | 2024-06-28 | 2024-08-06 | 1,736 | $12.24 | $21.2K | 161,834 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award | 2024-06-28 | 2024-08-06 | 1,286 | $12.24 | $15.7K | 220,465 | SEC↗ |
| Danziger Asaf | Chief Executive Officer | A Award | 2024-06-28 | 2024-08-06 | 1,239 | $12.24 | $15.2K | 15,228 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2024-06-28 | 2024-08-06 | 1,055 | $12.24 | $12.9K | 252,290 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2024-06-28 | 2024-08-06 | 930 | $12.24 | $11.4K | 118,052 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| LEUNG GABRIEL | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| Scannell Timothy J | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| Stafford Kristin | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| Hung David | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| Madden Martin J. | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| Ocean Allyson J | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M Exercise deriv | 2024-06-05 | 2024-06-07 | 124,373 | $22.82 | $2.84M | 95,000 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 6,590 | SEC↗ |
| LEUNG GABRIEL | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 83,192 | SEC↗ |
| Scannell Timothy J | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 7,981 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 169,850 | SEC↗ |
| Stafford Kristin | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 4,053 | SEC↗ |
| Hung David | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 13,194 | SEC↗ |
| Madden Martin J. | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 19,673 | SEC↗ |
| Ocean Allyson J | Director | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 4,053 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M Exercise | 2024-06-05 | 2024-06-07 | 124,373 | $22.82 | $2.84M | 124,373 | SEC↗ |
| LEUNG GABRIEL | Director | S Sale | 2024-06-04 | 2024-06-06 | 964 | $23.89 | $23.0K | 78,175 | SEC↗ |
| Scannell Timothy J | Director | S Sale | 2024-06-04 | 2024-06-06 | 964 | $23.89 | $23.0K | 2,964 | SEC↗ |
| VERNON W ANTHONY | Director | S Sale | 2024-06-04 | 2024-06-06 | 964 | $23.89 | $23.0K | 164,833 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2024-03-04 | 2024-03-05 | 840 | $16.01 | $13.4K | 160,098 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2024-03-04 | 2024-03-05 | 1,217 | $16.01 | $19.5K | 251,235 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2024-03-01 | 2024-03-05 | 1,679 | $16.03 | $26.9K | 160,938 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2024-03-01 | 2024-03-05 | 2,107 | $16.03 | $33.8K | 252,452 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2024-02-28 | 2024-02-29 | 2,303 | $16.14 | $37.2K | 254,559 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | S Sale | 2024-02-28 | 2024-02-29 | 2,078 | $16.14 | $33.5K | 162,617 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 71,920 | $16.30 | $1.17M | 71,920 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award deriv | 2024-02-27 | 2024-02-29 | 125,078 | $16.30 | $2.04M | 125,078 | SEC↗ |
| Giladi Moshe | Chief Science Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 78,174 | $16.30 | $1.27M | 78,174 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 78,174 | $16.30 | $1.27M | 78,174 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 125,078 | $16.30 | $2.04M | 125,078 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award deriv | 2024-02-27 | 2024-02-29 | 109,443 | $16.30 | $1.78M | 109,443 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award deriv | 2024-02-27 | 2024-02-29 | 156,348 | $16.30 | $2.55M | 156,348 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 156,348 | $16.30 | $2.55M | 156,348 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2024-02-27 | 2024-02-29 | 47,034 | $16.30 | $766.7K | 256,862 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2024-02-27 | 2024-02-29 | 81,799 | $16.30 | $1.33M | 117,122 | SEC↗ |
| Giladi Moshe | Chief Science Officer | A Award | 2024-02-27 | 2024-02-29 | 51,124 | $16.30 | $833.3K | 69,771 | SEC↗ |
| Leupin Nicolas | Chief Medical Officer | A Award | 2024-02-27 | 2024-02-29 | 51,124 | $16.30 | $833.3K | 51,124 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award | 2024-02-27 | 2024-02-29 | 81,799 | $16.30 | $1.33M | 171,148 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2024-02-27 | 2024-02-29 | 71,574 | $16.30 | $1.17M | 109,167 | SEC↗ |
| Leonard Frank X | EVP, Pres., Novocure Oncolog | A Award | 2024-02-27 | 2024-02-29 | 102,249 | $16.30 | $1.67M | 164,695 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award | 2024-02-27 | 2024-02-29 | 102,249 | $16.30 | $1.67M | 219,867 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2023-12-31 | 2024-02-29 | 3 | $12.69 | $38 | 209,828 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2023-12-31 | 2024-02-29 | 128 | $12.69 | $1.6K | 35,323 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-11-07 | 2023-11-08 | 382 | $12.65 | $4.8K | 124,511 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise deriv | 2023-11-02 | 2023-11-02 | 175 | — | $0 | 0 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise | 2023-11-02 | 2023-11-02 | 175 | $11.46 | $2.0K | 117,618 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 7,561 | — | $0 | 175 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 7,752 | — | $0 | 0 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 2,480 | — | $0 | 0 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award deriv | 2023-10-31 | 2023-11-03 | 57,604 | $13.30 | $766.1K | 57,604 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise | 2023-10-31 | 2023-11-02 | 2,480 | $11.44 | $28.4K | 109,691 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise | 2023-10-31 | 2023-11-02 | 7,752 | $7.15 | $55.4K | 117,443 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | M Exercise | 2023-10-31 | 2023-11-02 | 7,561 | $11.46 | $86.6K | 107,211 | SEC↗ |
| Puri Michal Nath | Chief Human Resources Office | A Award | 2023-10-31 | 2023-11-03 | 37,593 | — | $0 | 37,593 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-09-01 | 2023-09-05 | 273 | $21.82 | $6.0K | 124,893 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-09-01 | 2023-09-05 | 294 | $21.82 | $6.4K | 209,825 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-09-01 | 2023-09-05 | 883 | $21.82 | $19.3K | 99,650 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-08-02 | 2023-08-04 | 1,144 | $30.25 | $34.6K | 100,533 | SEC↗ |
| Danziger Asaf | Chief Executive Officer | A Award | 2023-06-30 | 2023-07-06 | 367 | $35.28 | $12.9K | 13,989 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award | 2023-06-30 | 2023-07-06 | 367 | $35.28 | $12.9K | 101,677 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award | 2023-06-30 | 2023-07-06 | 288 | $35.28 | $10.2K | 35,195 | SEC↗ |
| Burke William Patrick | Chief Human Resources Office | A Award | 2023-06-30 | 2023-07-06 | 357 | $35.28 | $12.6K | 66,447 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | A Award | 2023-06-30 | 2023-07-06 | 367 | $35.28 | $12.9K | 125,166 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2023-06-30 | 2023-07-06 | 366 | $35.28 | $12.9K | 210,119 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award | 2023-06-30 | 2023-07-06 | 305 | $35.28 | $10.8K | 89,349 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,554 | — | $0 | 12,554 | SEC↗ |
| LEUNG GABRIEL | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 6,277 | — | $0 | 6,277 | SEC↗ |
| Madden Martin J. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,554 | — | $0 | 12,554 | SEC↗ |
| Hung David | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,554 | — | $0 | 12,554 | SEC↗ |
| Scannell Timothy J | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 6,277 | — | $0 | 6,277 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 6,277 | — | $0 | 6,277 | SEC↗ |
| LEUNG GABRIEL | Director | A Award | 2023-06-07 | 2023-06-09 | 3,853 | — | $0 | 79,139 | SEC↗ |
| Scannell Timothy J | Director | A Award | 2023-06-07 | 2023-06-09 | 3,853 | — | $0 | 3,928 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2023-06-07 | 2023-06-09 | 3,853 | — | $0 | 165,797 | SEC↗ |
| Stafford Kristin | Director | A Award deriv | 2023-05-09 | 2023-05-11 | 15,873 | — | $0 | 15,873 | SEC↗ |
| Stafford Kristin | Director | A Award deriv | 2023-05-09 | 2023-05-17 | 15,873 | — | $0 | 15,873 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-07 | 2023-03-07 | 2,315 | $75.59 | $175.0K | 54,284 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-07 | 2023-03-07 | 6,003 | $75.00 | $450.2K | 56,599 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-03 | 2023-03-06 | 2,059 | $77.64 | $159.9K | 67,893 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | A Award | 2023-03-03 | 2023-03-06 | 11,808 | — | $0 | 69,952 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award | 2023-03-03 | 2023-03-06 | 11,808 | — | $0 | 106,815 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2023-03-03 | 2023-03-06 | 48,050 | — | $0 | 231,452 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award | 2023-03-03 | 2023-03-06 | 3,936 | — | $0 | 235,388 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | A Award | 2023-03-03 | 2023-03-06 | 3,936 | — | $0 | 102,974 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | A Award | 2023-03-03 | 2023-03-06 | 43,246 | — | $0 | 146,220 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award | 2023-03-03 | 2023-03-06 | 3,936 | — | $0 | 89,044 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award | 2023-03-03 | 2023-03-06 | 28,830 | — | $0 | 85,108 | SEC↗ |
| Burke William Patrick | Chief Human Resources Office | S Sale | 2023-03-03 | 2023-03-07 | 593 | $76.16 | $45.2K | 66,090 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-03-03 | 2023-03-07 | 4,730 | $76.16 | $360.2K | 102,085 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-03-03 | 2023-03-07 | 775 | $76.16 | $59.0K | 101,310 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-03-03 | 2023-03-07 | 3,528 | $76.16 | $268.7K | 231,860 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-03-03 | 2023-03-07 | 1,692 | $76.16 | $128.9K | 230,168 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-03-03 | 2023-03-07 | 20,415 | $76.16 | $1.55M | 209,753 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-03-03 | 2023-03-07 | 1,570 | $76.16 | $119.6K | 144,650 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-03-03 | 2023-03-07 | 2,942 | $76.16 | $224.1K | 141,708 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-03-03 | 2023-03-07 | 16,909 | $76.16 | $1.29M | 124,799 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-03 | 2023-03-07 | 4,403 | $76.16 | $335.3K | 63,490 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-03 | 2023-03-07 | 888 | $76.16 | $67.6K | 62,602 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-02 | 2023-03-03 | 308 | $76.05 | $23.4K | 58,988 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-02 | 2023-03-03 | 3,799 | $75.32 | $286.1K | 59,296 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-02 | 2023-03-06 | 844 | $75.28 | $63.5K | 58,144 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-03-02 | 2023-03-06 | 1,055 | $75.28 | $79.4K | 95,007 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-03-02 | 2023-03-06 | 1,213 | $75.28 | $91.3K | 183,402 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-03-02 | 2023-03-06 | 937 | $75.28 | $70.5K | 99,038 | SEC↗ |
| Burke William Patrick | Chief Human Resources Office | S Sale | 2023-03-02 | 2023-03-06 | 281 | $75.28 | $21.2K | 66,683 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S Sale | 2023-03-01 | 2023-03-02 | 2,164 | $76.36 | $165.2K | 184,615 | SEC↗ |
| Burke William Patrick | Chief Human Resources Office | S Sale | 2023-03-01 | 2023-03-02 | 755 | $76.36 | $57.7K | 66,964 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | S Sale | 2023-03-01 | 2023-03-02 | 2,198 | $76.36 | $167.8K | 96,062 | SEC↗ |
| Shah Pritesh | Chief Growth Officer | S Sale | 2023-03-01 | 2023-03-02 | 1,923 | $76.36 | $146.8K | 99,975 | SEC↗ |
| Leonard Frank X | President, CNS Cancers US | S Sale | 2023-03-01 | 2023-03-02 | 1,684 | $76.36 | $128.6K | 63,095 | SEC↗ |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 36,013 | $76.97 | $2.77M | 36,013 | SEC↗ |
| Burke William Patrick | Chief Human Resources Office | A Award deriv | 2023-02-28 | 2023-03-02 | 20,168 | $76.97 | $1.55M | 20,168 | SEC↗ |
| Cordova Ashley | Chief Financial Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 39,614 | $76.97 | $3.05M | 39,614 | SEC↗ |
| Ben Arye Barak | General Counsel | A Award deriv | 2023-02-28 | 2023-03-02 | 29,531 | $76.97 | $2.27M | 29,531 | SEC↗ |
| Weinberg Uri | Chief Innovation Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 21,607 | $76.97 | $1.66M | 21,607 | SEC↗ |